5. Conclusion
TNF-α
RECURRENCE
GVM therapy effectively reduced the PASI and DLQI scores, reduced PS recurrence, and regulated the levels of IL-17, IL-10, IL-4, TNF-α, and IFN-γ in the peripheral blood of patients with mild to moderate PS.